Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin capsule in COVID-19
IRCT20180103038199N10Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in coronavirus disease 2019 (COVID-19), sponsored by Mashhad University of Medical Sciences. Started Feb 2022; status: completed.
02
Drugs
silymarin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20180103038199N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038199N10.